Renal artery ablation instead of pulmonary vein ablation in a hypertensive patient with symptomatic, drug-resistant, persistent atrial fibrillation

go back to reference Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. (2012) HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European heart rhythm association (EHRA), a registered branch of the European society of cardiology (ESC) and the European cardiac arrhythmia society (ECAS); and in collaboration with the American college of cardiology (ACC), American heart association (AHA), the Asia pacific heart rhythm society (APHRS), and the society of thoracic surgeons (STS). Endorsed by the governing bodies of the American college of cardiology foundation, the American heart association, the European cardiac arrhythmia society, the European heart rhythm association, the society of thoracic surgeons, the Asia pacific heart rhythm society, and the heart rhythm society. Heart Rhythm;9(4):632–696 e21 Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. (2012) HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European heart rhythm association (EHRA), a registered branch of the European society of cardiology (ESC) and the European cardiac arrhythmia society (ECAS); and in collaboration with the American college of cardiology (ACC), American heart association (AHA), the Asia pacific heart rhythm society (APHRS), and the society of thoracic surgeons (STS). Endorsed by the governing bodies of the American college of cardiology foundation, the American heart association, the European cardiac arrhythmia society, the European heart rhythm association, the society of thoracic surgeons, the Asia pacific heart rhythm society, and the heart rhythm society. Heart Rhythm;9(4):632–696 e21

go back to reference Nault I, Miyazaki S, Forclaz A, Wright M, Jadidi A, Jais P et al (2010) Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation. Eur Heart J 31(9):1046–1054PubMedCrossRef Nault I, Miyazaki S, Forclaz A, Wright M, Jadidi A, Jais P et al (2010) Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation. Eur Heart J 31(9):1046–1054PubMedCrossRef

go back to reference Arya A, Hindricks G, Sommer P, Huo Y, Bollmann A, Gaspar T et al (2010) Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients. Europace 12(2):173–180PubMedCrossRef Arya A, Hindricks G, Sommer P, Huo Y, Bollmann A, Gaspar T et al (2010) Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients. Europace 12(2):173–180PubMedCrossRef

go back to reference Machino-Ohtsuka T, Seo Y, Tada H, Ishizu T, Machino T, Yamasaki H et al (2011) Left atrial stiffness relates to left ventricular diastolic dysfunction and recurrence after pulmonary vein isolation for atrial fibrillation. J Cardiovasc Electrophysiol 22(9):999–1006PubMedCrossRef Machino-Ohtsuka T, Seo Y, Tada H, Ishizu T, Machino T, Yamasaki H et al (2011) Left atrial stiffness relates to left ventricular diastolic dysfunction and recurrence after pulmonary vein isolation for atrial fibrillation. J Cardiovasc Electrophysiol 22(9):999–1006PubMedCrossRef

go back to reference Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity HTN-2 trial): a randomised controlled trial. Lancet 376(9756):1903–1909PubMedCrossRef Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity HTN-2 trial): a randomised controlled trial. Lancet 376(9756):1903–1909PubMedCrossRef

go back to reference Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275–1281PubMedCrossRef Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275–1281PubMedCrossRef

go back to reference Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361(9):932–934PubMedCrossRef Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361(9):932–934PubMedCrossRef

go back to reference Burke GM, Sica DA, Frishman WH (2012) Renal sympathetic denervation for the treatment of systemic hypertension. Cardiol Rev 20(6):274–278. doi:10.1097/CRD.0b013e3182651f91 PubMedCrossRef Burke GM, Sica DA, Frishman WH (2012) Renal sympathetic denervation for the treatment of systemic hypertension. Cardiol Rev 20(6):274–278. doi:10.​1097/​CRD.​0b013e3182651f91​ PubMedCrossRef

go back to reference Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Bohm M et al (2012) Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 59(10):901–909PubMedCrossRef Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Bohm M et al (2012) Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 59(10):901–909PubMedCrossRef

go back to reference Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K et al (2012) Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension 60(1):172–178PubMedCrossRef Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K et al (2012) Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension 60(1):172–178PubMedCrossRef

go back to reference Zhao Q, Yu S, Zou M, Dai Z, Wang X, Xiao J et al (2012) Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing. J Interv Card Electrophysiol 35(2):119–125. doi:10.1007/s10840-012-9717-y PubMedCrossRef Zhao Q, Yu S, Zou M, Dai Z, Wang X, Xiao J et al (2012) Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing. J Interv Card Electrophysiol 35(2):119–125. doi:10.​1007/​s10840-012-9717-y PubMedCrossRef

go back to reference Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A et al (2012) A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol 60(13):1163–1170PubMedCrossRef Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A et al (2012) A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol 60(13):1163–1170PubMedCrossRef

go back to reference Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, Bohm M, Krum H (2011) Sympatho-renal axis in chronic disease. Clin Res Cardiol 100(12):1049–1057PubMedCrossRef Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, Bohm M, Krum H (2011) Sympatho-renal axis in chronic disease. Clin Res Cardiol 100(12):1049–1057PubMedCrossRef

go back to reference Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C et al (2012) Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol 101(1):63–67PubMedCrossRef Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C et al (2012) Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol 101(1):63–67PubMedCrossRef